ARTICLE | Clinical News
Paliperidone ER regulatory update
May 8, 2006 7:00 AM UTC
JNJ subsidiary Janssen-Cilag (Beerse, Belgium) submitted an MAA to EMEA for paliperidone prolonged-release tablets to treat schizophrenia. An NDA for paliperidone for the same indication also is under...